Agback, Tatiana
- Medivir AB
A series of P1-P3 linked macrocyclic BACE-1 inhibitors containing a hydroxyethylamine (HEA) isostere scaffold has been synthesized. All inhibitors comprise a toluene or N-phenylmethanesulfonamide P2 moiety. Excellent BACE-1 potencies, both in enzymatic and cell-based assays, were observed in this series of target compounds, with the best candidates displaying cell-based IC50 values in the low nanomolar range. As an attempt to improve potency, a phenyl substituent aiming at the S3 subpocket was introduced in the macrocyclic ring. X-ray analyzes were performed on selected compounds, and enzyme-inhibitor interactions are discussed. (C) 2012 Elsevier Ltd. All rights reserved.
Alzheimer's disease; BACE-1 inhibition; Macrocycles; Hydroxyethylamine (HEA) isostere
Bioorganic and Medicinal Chemistry
2012, volume: 20, number: 14, pages: 4377-4389
Publisher: PERGAMON-ELSEVIER SCIENCE LTD
Medicinal Chemistry
https://res.slu.se/id/publ/99462